These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32339553)

  • 41. Editorial: Recent developments in the Application of Separation and Hyphenated Techniques in Current Diagnostic Challenges.
    Stepnowski P; Paszkiewicz M
    Curr Med Chem; 2019; 26(1):3-4. PubMed ID: 30900540
    [No Abstract]   [Full Text] [Related]  

  • 42. [The diagnostic value of systemic inflammation biomarkers in chronic obstructive pulmonary disease].
    Budnevskii AV; Ovsiannikov ES; Chernov AV; Drobysheva ES
    Klin Med (Mosk); 2014; 92(9):16-21. PubMed ID: 25790706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
    Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
    BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Lipidomic Biomarkers in Hyperlipidemia and Cardiovascular Diseases: An Integrative Biology Analysis.
    Rai S; Bhatnagar S
    OMICS; 2017 Mar; 21(3):132-142. PubMed ID: 28157411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.
    Cazzola M; Puxeddu E; Ora J; Rogliani P
    Mol Diagn Ther; 2019 Oct; 23(5):603-614. PubMed ID: 31363933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal biomarkers for the prediction of cardiovascular disease.
    Joshi S; Viljoen A
    Curr Opin Cardiol; 2015 Jul; 30(4):454-60. PubMed ID: 26049396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.
    Lopez-Campos JL; Calero-Acuña C; Lopez-Ramirez C; Abad-Arranz M; Márquez-Martín E; Ortega-Ruiz F; Arellano E
    Biomark Med; 2016; 10(2):109-22. PubMed ID: 26808692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarkers of Cardiac Health and Disease.
    Sinha PK; Sinha ES; Kaur J
    Crit Rev Biomed Eng; 2019; 47(5):395-407. PubMed ID: 32422029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Developing and assessing cardiovascular biomarkers.
    Dadu RT; Nambi V; Ballantyne CM
    Transl Res; 2012 Apr; 159(4):265-76. PubMed ID: 22424430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysis.
    McGranaghan P; Saxena A; Rubens M; Radenkovic J; Bach D; Schleußner L; Pieske B; Edelmann F; Trippel TD
    Biomarkers; 2020 Mar; 25(2):101-111. PubMed ID: 31928240
    [No Abstract]   [Full Text] [Related]  

  • 51. Search for biomarkers in chronic obstructive pulmonary disease: current status.
    Nicholas BL
    Curr Opin Pulm Med; 2013 Mar; 19(2):103-8. PubMed ID: 23361193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipidomics of human brain aging and Alzheimer's disease pathology.
    Naudí A; Cabré R; Jové M; Ayala V; Gonzalo H; Portero-Otín M; Ferrer I; Pamplona R
    Int Rev Neurobiol; 2015; 122():133-89. PubMed ID: 26358893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sirtuin 1 and aging theory for chronic obstructive pulmonary disease.
    Conti V; Corbi G; Manzo V; Pelaia G; Filippelli A; Vatrella A
    Anal Cell Pathol (Amst); 2015; 2015():897327. PubMed ID: 26236580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine.
    Milne S; Sin DD
    Clin Chest Med; 2020 Sep; 41(3):383-394. PubMed ID: 32800193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ambient Air Pollution and Biomarkers of Health Effect.
    Yang D; Yang X; Deng F; Guo X
    Adv Exp Med Biol; 2017; 1017():59-102. PubMed ID: 29177959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease.
    Ooi H; Chen LH; Ni YL; Shen HT; Lee YH; Chu YC; Fang KC; Chen IH; Hsu SL; Chen HC; Huang CH; Fan KS; Lai CL; Hang LW
    Clin Respir J; 2018 Mar; 12(3):1038-1045. PubMed ID: 28268258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics].
    Ambatiello LG; Chazova IE
    Ter Arkh; 2020 Apr; 92(3):78-83. PubMed ID: 32598797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities.
    O'Neil SE; Lundbäck B; Lötvall J
    J Proteomics; 2011 Dec; 75(1):192-201. PubMed ID: 22037230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.